Amedeo Smart

Free Medical Literature Service

 

Amedeo

Schizophrenia
  Free Subscription

Articles published in
Psychol Med
    December 2025
  1. MIETTUNEN J, Ruotsalainen H, Vainio N, AlSaadi H, et al
    Specificity of environmental risk factors for schizophrenia, bipolar disorders, and depressive disorders - umbrella review.
    Psychol Med. 2025;55:e368.
    >> Share

    November 2025
  2. HAZAN H, Tayfur SN, Karmani S, Gibbs-Dean T, et al
    Instruments for assessing insight in psychosis: A systematic review of psychometric properties.
    Psychol Med. 2025;55:e362.
    >> Share

  3. AICOBOAIE S, Pappaianni E, Abdulkadir M, Davies HL, et al
    Genetic risk and transdiagnostic traits in anorexia nervosa, obsessive-compulsive disorder, and schizophrenia.
    Psychol Med. 2025;55:e360.
    >> Share

  4. SEIF P
    Mental time travel and insight in schizophrenia.
    Psychol Med. 2025;55:e357.
    >> Share

  5. LI C, Tse W, Chu ST, Zhou H, et al
    Long-term mortality and associated factors in first episode psychosis: a 25-year follow-up study.
    Psychol Med. 2025;55:e355.
    >> Share

  6. YU H, Wang W, Qiao M, Yang M, et al
    Network analysis of relationships among psychopathology, cognitive function, and psychosocial functioning in independent samples of Chinese with schizophrenia or bipolar disorder.
    Psychol Med. 2025;55:e353.
    >> Share

  7. MADSEN MK
    Comment on 'Dopamine D(2/3)R availability after discontinuation of antipsychotic treatment: a [(11)C]raclopride PET study in remitted first-episode psychosis patients' by de Beer et al. 2025.
    Psychol Med. 2025;55:e348.
    >> Share

  8. HO MTH, Chu RST, Lui TT, Lau FC, et al
    Three-year outcome comparison between extended early intervention and standard psychiatric care for adults with first-episode psychosis in Hong Kong.
    Psychol Med. 2025;55:e335.
    >> Share

    October 2025
  9. HYAT M, Zhu J, Boltz TA, Conomos MP, et al
    Independent versus joint effects of polygenic or family-based schizophrenia risk in diverse ancestry youth in the ABCD study.
    Psychol Med. 2025;55:e327.
    >> Share

  10. DJORDJEVIC M, Gangadin SS, de Haan L, Jongsma HE, et al
    Psychological side effects of antipsychotic medication after remission from first-episode psychosis: a HAMLETT ecological momentary assessment study.
    Psychol Med. 2025;55:e325.
    >> Share

  11. RABALLO A, Poletti M, Preti A
    Connecting the empirical dots on antipsychotic exposure and treatment in clinical high-risk for psychosis.
    Psychol Med. 2025;55:e320.
    >> Share

  12. LI Y, Yu M, Yang H, Shi L, et al
    Efficacy of adjunctive antidepressants in treating negative symptoms of schizophrenia: a systematic review and network meta-analysis.
    Psychol Med. 2025;55:e317.
    >> Share

  13. GERDES G, Song J, Service SK, Ramirez-Diaz AM, et al
    Socioeconomic and geographic disparities in psychiatric outcomes under Colombia's universal healthcare system.
    Psychol Med. 2025;55:e310.
    >> Share

  14. ZHANG Y, Wang H, Cai M, Wang W, et al
    From risk to chronicity: genetic and neuroimaging insights into the evolving patterns of spontaneous brain activity in schizophrenia.
    Psychol Med. 2025;55:e306.
    >> Share

  15. YAO S, Mo F, Rao Z, Shi Y, et al
    Network localization of genetic risk for schizophrenia and bipolar disorder.
    Psychol Med. 2025;55:e299.
    >> Share

    September 2025
  16. LIU KY, Perera G, Howard R, Mueller C, et al
    Cognitive trajectories and dementia risk in patients with schizophrenia spectrum versus affective disorders.
    Psychol Med. 2025;55:e286.
    >> Share

  17. MICHALOPOULOU PG, Meshreky KM, Hommerich Z, Shergill SS, et al
    Neuromodulation and neural networks in psychiatric disorders: current status and emerging prospects.
    Psychol Med. 2025;55:e281.
    >> Share

  18. BLOOMFIELD M, Modaffar M, Noar A, Walker C, et al
    Brain structure and function in adult survivors of developmental trauma with psychosis: A systematic review.
    Psychol Med. 2025;55:e272.
    >> Share

  19. YIN L, Liu M, Shi Y, Zhang R, et al
    Uncovering the genetic underpinnings for different psychiatric disorder combinations.
    Psychol Med. 2025;55:e270.
    >> Share

  20. DE BEER F, de Vries E, Wijnen B, Begemann MJH, et al
    Dopamine D(2/3)R availability after discontinuation of antipsychotic treatment: a [(11)C]raclopride PET study in remitted first-episode psychosis patients.
    Psychol Med. 2025;55:e264.
    >> Share

  21. ODUOLA S, Pathan S, Hodgekins J, Teague B, et al
    Ethnic disparities, clinical and pathways to care characteristics associated with the offer, uptake, and type of psychological therapy during first-episode psychosis: examining the role of early intervention for psychosis.
    Psychol Med. 2025;55:e262.
    >> Share

    August 2025
  22. SHAO X, Ren H, Dai L, He J, et al
    Progressive gray matter reduction in schizophrenia patients with persistent auditory hallucinations by causal structural covariance network analysis.
    Psychol Med. 2025;55:e255.
    >> Share

  23. LIU CI, Liu CM, Hsieh MH, Lin YT, et al
    Successful antipsychotic dose tapering leading to better cognition in patients with remitted psychosis: Results of Guided Antipsychotic Reduction to Reach Minimum Effective Dose (GARMED) trial.
    Psychol Med. 2025;55:e247.
    >> Share

  24. MUKHTAR H, Zhou D, Farina EA, Saxena A, et al
    Prediction of antipsychotic medication inception in antipsychotic-naive youth at clinical high risk for psychosis.
    Psychol Med. 2025;55:e241.
    >> Share

  25. SUN T, Zhu Y, Zhao P, Zhao W, et al
    Impact of schizophrenia-associated risk genes on brain functional networks and executive deficits: a study of individuals with schizophrenia and genetic high risk.
    Psychol Med. 2025;55:e240.
    >> Share

  26. KENDLER KS, Ohlsson H, Sundquist J, Sundquist K, et al
    The outcome of major psychiatric and substance use disorders as an index of genetic risk and genetic heterogeneity.
    Psychol Med. 2025;55:e233.
    >> Share

  27. GANNON L, Teague V, Oduola S, McNicholas F, et al
    The proportion of people with a first episode of psychosis admitted to hospital at initial presentation: a systematic review and meta-analysis.
    Psychol Med. 2025;55:e228.
    >> Share

  28. SONG Y, Zeng J, Cao H, Cheng B, et al
    Neurofunctional representations of instrumental learning in psychosis: a meta-analysis of neuroimaging studies.
    Psychol Med. 2025;55:e229.
    >> Share

  29. LIVINGSTON NR, Kiemes A, O'Daly O, Knight SR, et al
    Diazepam modulates hippocampal CA1 functional connectivity in people at clinical high-risk for psychosis.
    Psychol Med. 2025;55:e230.
    >> Share

  30. CUESTA MJ, Gil-Berrozpe GJ, Sanchez-Torres AM, Moreno-Izco L, et al
    Multidimensional outcome of first-episode psychosis: a network analysis - CORRIGENDUM.
    Psychol Med. 2025;55:e222.
    >> Share

    July 2025
  31. MENA S, Coutts F, von Trott J, Ucur E, et al
    AI-based prediction of depression symptomatology in first-episode psychosis patients: insights from the EUFEST and RAISE-ETP clinical trials.
    Psychol Med. 2025;55:e221.
    >> Share

  32. HUANG Y, He J, Zhang X, Chen J, et al
    Leveraging stacked classifiers for exploring the role of hedonic processing between major depressive disorder and schizophrenia.
    Psychol Med. 2025;55:e211.
    >> Share

  33. COSTAS-CARRERA A, Verdolini N, Mezquida G, Forte MF, et al
    Obstetric complications, cortical gyrification, and cognition in first-episode psychosis.
    Psychol Med. 2025;55:e209.
    >> Share

  34. CONEJEROS-PAVEZ J, Vasquez J, Diaz C, Mena C, et al
    Premorbid school performance trajectories in patients with treatment-resistant schizophrenia prescribed clozapine in the public health system in Chile: a case-control study, 2007-2020.
    Psychol Med. 2025;55:e205.
    >> Share

  35. WALTZ JA, Pujji SD, Colloca L
    Placebo and nocebo phenomena in schizophrenia spectrum disorders: a narrative review on current knowledge and potential future directions.
    Psychol Med. 2025;55:e199.
    >> Share

  36. HAJNAL A, Csulak T, Hebling D, Farkas Borbasne K, et al
    Spontaneous mentalizing in patients with schizophrenia spectrum disorders: a meta-analysis.
    Psychol Med. 2025;55:e195.
    >> Share

    June 2025
  37. VAN DE WEIJER MP, Liu S, Thijssen AB, Wootton RE, et al
    The causal effect of smoking on psychiatric disorders: an examination of brain volume as a potential pathway.
    Psychol Med. 2025;55:e171.
    >> Share

    May 2025
  38. FLINN A, Hefferman-Clarke R, Parker S, Allsopp K, et al
    Cumulative exposure to childhood adversity and risk of adult psychosis: a dose-response meta-analysis.
    Psychol Med. 2025;55:e162.
    >> Share

  39. DRYMONITOU G, McCulloch A, Parry S, Gough R, et al
    The association between disordered eating and psychosis in clinical and non-clinical populations: a systematic review and meta-analysis.
    Psychol Med. 2025;55:e160.
    >> Share

  40. FRILIGKOU E, Pathak GA, Tylee DS, De Lillo A, et al
    Characterizing pleiotropy among bipolar disorder, schizophrenia, and major depression: a genome-wide cross-disorder meta-analysis.
    Psychol Med. 2025;55:e145.
    >> Share

  41. PIKE B, Ambrosio L, Ellett L
    Brief psychological interventions for schizophrenia: a systematic review and meta-analysis.
    Psychol Med. 2025;55:e146.
    >> Share

  42. WADDINGTON JL
    From genetics and cerebral asymmetry, through motor dysfunction intrinsic to psychosis, to early intervention: elaborating the seminal contributions of Timothy J. Crow.
    Psychol Med. 2025;55:e143.
    >> Share

  43. PERALTA V, Moreno-Izco L, Garcia de Jalon E, Sanchez-Torres AM, et al
    Lifetime suicidal thoughts, attempts, and lethality of attempts as major outcome domains of psychotic disorders: a 21-year prospective cohort study after a first-episode psychosis - CORRIGENDUM.
    Psychol Med. 2025;55:e136.
    >> Share

  44. SERIMAA O, Keltikangas-Jarvinen L, Lyytikainen LP, Hietala J, et al
    Polygenic risk for schizophrenia and subjective well-being in a general population sample.
    Psychol Med. 2025;55:e133.
    >> Share

    April 2025
  45. FENG Y, Wong KC, Leung PB, Lee BK, et al
    Longitudinal impact of different treatment sequences of second-generation antipsychotics on metabolic outcomes: a study using targeted maximum likelihood estimation.
    Psychol Med. 2025;55:e123.
    >> Share

  46. JEON E, Li L, Le TH, Kim WS, et al
    Virtual reality therapy targeting ideas of reference in patients with psychosis: a single-blind parallel-group randomized controlled trial.
    Psychol Med. 2025;55:e121.
    >> Share

  47. CEDERLOF E, Holm M, Kampe A, Ahola-Olli A, et al
    Sleep and schizophrenia polygenic scores in non-affective and affective psychotic disorders.
    Psychol Med. 2025;55:e117.
    >> Share

  48. STRAKELJAHN F, Lincoln TM, Schlier B
    Predicting experiences of paranoia and auditory verbal hallucinations in daily life with ambulatory sensor data - A feasibility study.
    Psychol Med. 2025;55:e114.
    >> Share

  49. RAMI FZ, Seo H, Kang C, Park S, et al
    Associations of polygenic risk score, environmental factors, and their interactions with the risk of schizophrenia spectrum disorders.
    Psychol Med. 2025;55:e111.
    >> Share

  50. CHEN YHE, Wong SMY, So MM, Suen YN, et al
    Spurious autobiographical memories of psychosis: a dopamine-gated neuroplasticity account for relapse and treatment-resistant psychosis.
    Psychol Med. 2025;55:e14.
    >> Share

  51. KIESEPPA V, Lang U, Healy C, O'Hare K, et al
    Do psychotic symptoms predict future psychotic disorders in adolescent psychiatry inpatients? A 17-year cohort study.
    Psychol Med. 2025;55:e108.
    >> Share

    March 2025
  52. SIMONSSON O, Goldberg SB, Osika W, Stenfors CUD, et al
    Longitudinal associations of naturalistic psychedelic use with psychotic and manic symptoms.
    Psychol Med. 2025;55:e99.
    >> Share

  53. HAN Y, Wang X, Cheng S, Yan P, et al
    Cortical morphometric similarity gradient in schizophrenia and its association with transcriptional profiles and clinical phenotype.
    Psychol Med. 2025;55:e97.
    >> Share

  54. UPADHYAYA S, Sucksdorff D, Koskela M, Cheslack-Postava K, et al
    Parental psychiatric disorders and age-specific risk for offspring major depression: Finnish nationwide register-based study.
    Psychol Med. 2025;55:e96.
    >> Share

  55. BIRIA M, Banca P, Barnham IJ, Marzuki AA, et al
    Clozapine-induced obsessive-compulsive symptoms in schizophrenia: Clinical and cognitive determinants of dysfunctional checking.
    Psychol Med. 2025;55:e87.
    >> Share

  56. SCOTT I, Aarts E, Wannan C, Gao CX, et al
    Characterising symptomatic substates in individuals on the psychosis continuum: a hidden Markov modelling approach.
    Psychol Med. 2025;55:e82.
    >> Share

  57. BORREGO-RUIZ A, Borrego JJ
    Involvement of virus infections and antiviral agents in schizophrenia.
    Psychol Med. 2025;55:e73.
    >> Share

  58. MULLIGAN LD, Varese F, Harris K, Haddock G, et al
    Cannabis use and suicide in people with a diagnosis of schizophrenia: a systematic review and meta-analysis of longitudinal, case control, and cross-sectional studies.
    Psychol Med. 2025;55:e79.
    >> Share

  59. PALANIYAPPAN L, Liddle PF
    Seminal Contributions of Timothy J. Crow.
    Psychol Med. 2025;55:e75.
    >> Share

  60. PERALTA V, Moreno-Izco L, de Jalon EG, Sanchez-Torres AM, et al
    Lifetime suicidal thoughts, attempts, and lethality of attempts as major outcome domains of psychotic disorders: a 21-year prospective cohort study after a first-episode psychosis.
    Psychol Med. 2025;55:e69.
    >> Share

  61. WATSON AJ, Stringer D, Pickles A, McCrone P, et al
    A network approach exploring the effects of cognitive remediation on cognition, symptoms, and functioning in early psychosis.
    Psychol Med. 2025;55:e66.
    >> Share

  62. CAVELTI M, Kaeser JM, Sele S, Berger T, et al
    The relationship between stress and clinical high-risk symptoms of psychosis in daily life: impact of contemporaneous paths on cross-lagged effects.
    Psychol Med. 2025;55:e68.
    >> Share

    February 2025
  63. HEMAGER N, Gjode ICT, Gregersen M, Brandt JM, et al
    Family functioning in families with 11-year-old children at familial high risk of schizophrenia or bipolar disorder and population-based controls: The Danish High Risk and Resilience Study VIA 11.
    Psychol Med. 2025;55:e62.
    >> Share

  64. JOO SW, Lee J, Han J, Kim M, et al
    Disparities in accelerated brain aging in recent-onset and chronic schizophrenia.
    Psychol Med. 2025;55:e60.
    >> Share

  65. PANAYI P, Contreras A, Peters E, Bentall R, et al
    A temporal network analysis of complex post-traumatic stress disorder and psychosis symptoms.
    Psychol Med. 2025;55:e43.
    >> Share

  66. GARCIA-LEON MA, Fuentes-Claramonte P, Gee A, Ramiro-Sousa N, et al
    Are delusions and/or referentiality associated with aberrant reward prediction error (RPE) signaling? Evidence from fMRI using a probabilistic monetary reward task.
    Psychol Med. 2025;55:e55.
    >> Share

  67. FREEMAN D, Waite F
    Sleep and circadian difficulties in schizophrenia: presentations, understanding, and treatment.
    Psychol Med. 2025;55:e47.
    >> Share

  68. MAXIMO J, Nelson E, Kraguljac N, Patton R, et al
    Changes in glutamate levels in anterior cingulate cortex following 16 weeks of antipsychotic treatment in antipsychotic-naive first-episode psychosis patients.
    Psychol Med. 2025;55:e35.
    >> Share

  69. TSAI SJ, Cheng CM, Chang WH, Bai YM, et al
    Panic disorder and suicide.
    Psychol Med. 2025;55:e38.
    >> Share

  70. LUTHER L, Raugh IM, Strauss GP
    Probabalistic reinforcement learning impairments predict negative symptom severity and risk for conversion in youth at clinical high-risk for psychosis.
    Psychol Med. 2025;55:e28.
    >> Share

  71. CUESTA MJ, Gil-Berrozpe GJ, Sanchez-Torres AM, Moreno-Izco L, et al
    Multidimensional outcome of first-episode psychosis: a network analysis.
    Psychol Med. 2025;55:e29.
    >> Share

  72. STRAUSS GP, Raugh I, Visser K, Walker E, et al
    Deconstructing the nature of emotion regulation impairments at the identification, selection, and implementation stages in individuals at clinical high-risk for psychosis.
    Psychol Med. 2025;55:e22.
    >> Share

  73. FERRARO L, Di Forti M, La Barbera D, La Cascia C, et al
    Cognitive presentation at psychosis onset through premorbid deterioration and exposure to environmental risk factors.
    Psychol Med. 2025;55:e12.
    >> Share

  74. SAPERIA S, Plahouras J, Best M, Kidd S, et al
    The cognitive model of negative symptoms: a systematic review and meta-analysis of the dysfunctional belief systems associated with negative symptoms in schizophrenia spectrum disorders.
    Psychol Med. 2025;55:e11.
    >> Share

  75. SARGENT K, Martinez E, Reed A, Guha A, et al
    Brain-body dysconnectivity: deficient autonomic regulation of cortical function in first-episode schizophrenia.
    Psychol Med. 2025;55:e1.
    >> Share

    January 2025
  76. SEE CRZ, Si S, Hedges E, Tognin S, et al
    The effects of recent stressful life events on outcomes in individuals at clinical high risk for psychosis: results from the longitudinal EU-GEI high-risk study.
    Psychol Med. 2025 Jan 8:1-11. doi: 10.1017/S0033291724003039.
    >> Share

  77. DAUVERMANN MR, Costello L, Tronchin G, Corley E, et al
    Cellular and extracellular white matter alterations after childhood trauma experience in individuals with schizophrenia.
    Psychol Med. 2025 Jan 6:1-10. doi: 10.1017/S0033291724003064.
    >> Share

    December 2024
  78. PYLE M, Corrigan PW, Wood L, Pilling S, et al
    A feasibility randomized controlled trial of an individually delivered, peer support intervention to reduce the impact of psychosis stigma and discrimination for people with psychosis: the let's talk study.
    Psychol Med. 2024 Dec 27:1-12. doi: 10.1017/S0033291724002605.
    >> Share

  79. FARES-OTERO NE, Verdolini N, Melero H, Andres-Camazon P, et al
    Triangulating the associations of different types of childhood adversity and first-episode psychosis with cortical thickness across brain regions.
    Psychol Med. 2024 Dec 16:1-14. doi: 10.1017/S0033291724002393.
    >> Share

  80. XU R, Zhang X, Zhou S, Guo L, et al
    Brain structural damage networks at different stages of schizophrenia.
    Psychol Med. 2024 Dec 11:1-11. doi: 10.1017/S0033291724003088.
    >> Share

  81. STROMME MF, Thue Augustsson M, Bartz-Johannessen C, Stautland A, et al
    Suicidality and use of psychotropic medications in patients with schizophrenia: a prospective cohort study.
    Psychol Med. 2024 Dec 9:1-9. doi: 10.1017/S0033291724002873.
    >> Share

  82. FROST R, Collier O, Hardy A
    Are trauma-related beliefs associated with psychosis symptoms? A systematic review and meta-analysis.
    Psychol Med. 2024 Dec 9:1-10. doi: 10.1017/S0033291724002629.
    >> Share

  83. AUSTIN-ZIMMERMAN I, Spinazzola E, Quattrone D, Wu-Choi B, et al
    The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies.
    Psychol Med. 2024 Dec 6:1-13. doi: 10.1017/S0033291724002058.
    >> Share

  84. YEH D, He Q, Krebs E, Iftimovici A, et al
    Cognitive impairment in the schizophrenia spectrum: exploring the relationships of the g-factor with sociodemography, psychopathology, neurodevelopment, and genetics.
    Psychol Med. 2024 Dec 2:1-12. doi: 10.1017/S0033291724002538.
    >> Share

  85. YANG KC, Yang BH, Lan CC, Liu MN, et al
    Striatal and peripheral dopaminergic alterations related to cognitive impairment in patients with schizophrenia.
    Psychol Med. 2024 Dec 2:1-11. doi: 10.1017/S0033291724002228.
    >> Share

  86. SKLAR AL, Matinrazm S, Esseku A, Lopez-Caballero F, et al
    Longitudinal evaluation of the early auditory gamma-band response and its modulation by attention in first-episode psychosis.
    Psychol Med. 2024 Dec 2:1-9. doi: 10.1017/S0033291724003052.
    >> Share

    November 2024
  87. O'DONOGHUE B, Oliver D, Geros H, Sizer H, et al
    Enriching ultra-high risk for psychosis cohorts based on accumulated exposure to environmental risk factors for psychotic disorders.
    Psychol Med. 2024 Nov 25:1-9. doi: 10.1017/S0033291724002551.
    >> Share

  88. ROLDAN L, Sanchez-Gutierrez T, Fernandez-Arias I, Rodriguez-Toscano E, et al
    Cannabis use and cognitive biases in people with first-episode psychosis and their siblings.
    Psychol Med. 2024 Nov 22:1-11. doi: 10.1017/S0033291724001715.
    >> Share

  89. YAO G, Luo J, Li J, Feng K, et al
    Functional gradient dysfunction in drug-naive first-episode schizophrenia and its correlation with specific transcriptional patterns and treatment predictions.
    Psychol Med. 2024 Nov 18:1-13. doi: 10.1017/S0033291724001739.
    >> Share

  90. HANSEN HG, Speyer H, Sturup AE, Hjorthoj C, et al
    Use and discontinuation of antipsychotic medication in 20 years following a first episode of schizophrenia: results from the OPUS trial.
    Psychol Med. 2024 Nov 18:1-11. doi: 10.1017/S0033291724002678.
    >> Share

  91. ROELL L, Fischer T, Keeser D, Papazov B, et al
    Effects of aerobic exercise on hippocampal formation volume in people with schizophrenia - a systematic review and meta-analysis with original data from a randomized-controlled trial.
    Psychol Med. 2024 Nov 18:1-12. doi: 10.1017/S0033291724001867.
    >> Share

  92. YANG J, Liu Z, Pan Y, Fan Z, et al
    Regional neural functional efficiency across schizophrenia, bipolar disorder, and major depressive disorder: a transdiagnostic resting-state fMRI study.
    Psychol Med. 2024 Nov 18:1-12. doi: 10.1017/S0033291724001685.
    >> Share

    October 2024
  93. OKUDA T, Kimoto S, Kawabata R, Bian Y, et al
    Alterations in inhibitory neuron subtype-selective transcripts in the prefrontal cortex: comparisons across schizophrenia and mood disorders.
    Psychol Med. 2024 Oct 31:1-10. doi: 10.1017/S0033291724002344.
    >> Share

  94. ANTONUCCI LA, Raio A, Kikidis GC, Bertolino A, et al
    Personality changes during adolescence predict young adult psychosis proneness and mediate gene-environment interplays of schizophrenia risk.
    Psychol Med. 2024 Oct 28:1-11. doi: 10.1017/S0033291724002198.
    >> Share

  95. IFTIMOVICI A, Krebs E, Dalfin W, Legrand A, et al
    Neurodevelopmental predictors of treatment response in schizophrenia and bipolar disorder.
    Psychol Med. 2024 Oct 15:1-12. doi: 10.1017/S0033291724001776.
    >> Share

  96. NOSTDAL A, Hilker R, Halgren C, Speyer H, et al
    Deprescribing antipsychotics in patients with schizophrenia: findings from a specialized clinic.
    Psychol Med. 2024 Oct 15:1-10. doi: 10.1017/S0033291724001910.
    >> Share

  97. KERR-GAFFNEY J, Nuerzati Y, Kopra EI, Young AH, et al
    Impulsivity in first-degree relatives at risk of psychosis and mania: a systematic review and meta-analysis.
    Psychol Med. 2024 Oct 14:1-9. doi: 10.1017/S0033291724001752.
    >> Share

  98. GOODING P, Harris K, Duxbury P, Pratt D, et al
    Influence of perceived harm due to substance use on the relationships between positive psychotic experiences and suicidal experiences in people with non-affective psychosis.
    Psychol Med. 2024 Oct 4:1-11. doi: 10.1017/S0033291724001764.
    >> Share

  99. PANAYI P, Peters E, Bentall R, Hardy A, et al
    Complex PTSD symptoms predict positive symptoms of psychosis in the flow of daily life.
    Psychol Med. 2024 Oct 4:1-12. doi: 10.1017/S0033291724001934.
    >> Share

    September 2024
  100. NKIRE N, Kinsella A, Russell V, Waddington JL, et al
    What is the duration of untreated psychosis worldwide?
    Psychol Med. 2024 Sep 26:1-3. doi: 10.1017/S0033291724002125.
    >> Share

  101. GIBSON LL, Mueller C, Stewart R, Aarsland D, et al
    Characteristics associated with progression to probable dementia with Lewy bodies in a cohort with very late-onset psychosis.
    Psychol Med. 2024 Sep 26:1-10. doi: 10.1017/S0033291724001922.
    >> Share

  102. SELTEN JP, Alrashed H, Oh H, Blokland GAM, et al
    Psychosis risk for lesbian, gay, and bisexual individuals: systematic review and meta-analysis.
    Psychol Med. 2024 Sep 25:1-10. doi: 10.1017/S0033291724002253.
    >> Share

  103. BRAMNESS JG, Hjorthoj C, Niemela S, Taipale H, et al
    Discussing the concept of substance-induced psychosis (SIP).
    Psychol Med. 2024 Sep 10:1-5. doi: 10.1017/S0033291724001442.
    >> Share

  104. GOLAY P, Abrahamyan Empson L, Mebdouhi N, Conchon C, et al
    Statistical implication analysis: a novel approach to understand the reciprocal relationships between outcomes in early psychosis.
    Psychol Med. 2024 Sep 9:1-6. doi: 10.1017/S0033291724001430.
    >> Share

  105. KRUGER E, Hall L, Martinez AP, Bentall RP, et al
    Cognitive behavioral self-help interventions for individuals experiencing psychosis: a systematic review.
    Psychol Med. 2024 Sep 9:1-11. doi: 10.1017/S0033291724001545.
    >> Share

  106. MARCHAM L, Ellett L
    Exposure to green spaces and schizophrenia: a systematic review.
    Psychol Med. 2024 Sep 9:1-12. doi: 10.1017/S0033291724001533.
    >> Share

  107. BORA E, Cesim E, Eyuboglu MS, Demir M, et al
    Effort-based decision-making in ultra-high-risk for psychosis and bipolar disorder.
    Psychol Med. 2024 Sep 6:1-9. doi: 10.1017/S003329172400134.
    >> Share

    August 2024
  108. BAEK JH, Lee D, Lee D, Jeong H, et al
    Exploring intra-diagnosis heterogeneity and inter-diagnosis commonality in genetic architectures of bipolar disorders: association of polygenic risks of major psychiatric illnesses and lifetime phenotype dimensions.
    Psychol Med. 2024;54:3082-3088.
    >> Share

    July 2024
  109. VAN HOOIJDONK CFM, Balvers MGJ, van der Pluijm M, Smith CLC, et al
    Endocannabinoid levels in plasma and neurotransmitters in the brain: a preliminary report on patients with a psychotic disorder and healthy individuals.
    Psychol Med. 2024;54:2189-2199.
    >> Share

  110. KENDLER KS, Ohlsson H, Sundquist J, Sundquist K, et al
    The genetic epidemiology of schizotypal personality disorder.
    Psychol Med. 2024;54:2144-2151.
    >> Share

    June 2024
  111. CHEN LG, Tubbs JD, Liu Z, Thach TQ, et al
    Mendelian randomization: causal inference leveraging genetic data.
    Psychol Med. 2024;54:1461-1474.
    >> Share

  112. GUIMOND S, Alftieh A, Devenyi GA, Mike L, et al
    Enlarged pituitary gland volume: a possible state rather than trait marker of psychotic disorders.
    Psychol Med. 2024;54:1835-1843.
    >> Share

  113. KENDLER KS, Ohlsson H, Sundquist J, Sundquist K, et al
    The predictive effect of family genetic risk scores as an indirect measure of causal effects of one disorder on another.
    Psychol Med. 2024;54:1867-1875.
    >> Share

  114. ZHANG Z, Wei W, Wang S, Li M, et al
    Dynamic structure-function coupling across three major psychiatric disorders.
    Psychol Med. 2024;54:1629-1640.
    >> Share

  115. ALKEMA A, Marchi M, van der Zaag JAJ, van der Sluis D, et al
    Childhood abuse v. neglect and risk for major psychiatric disorders.
    Psychol Med. 2024;54:1598-1609.
    >> Share

    May 2024
  116. PERALTA V, Garcia de Jalon E, Moreno-Izco L, Peralta D, et al
    The association of adverse childhood experiences with long-term outcomes of psychosis: a 21-year prospective cohort study after a first episode of psychosis.
    Psychol Med. 2024 May 30:1-10. doi: 10.1017/S0033291724001223.
    >> Share

  117. MAITRA R, Lemmers-Jansen ILJ, Vooren M, Vanes L, et al
    Understanding the mechanisms underlying cognitive control in psychosis.
    Psychol Med. 2024 May 23:1-10. doi: 10.1017/S0033291724001119.
    >> Share

  118. ANDERSON KK, Khan JA, Edwards J, Le B, et al
    Lost in translation? Deciphering the role of language differences in the excess risk of psychosis among migrant groups.
    Psychol Med. 2024 May 22:1-8. doi: 10.1017/S003329172400117.
    >> Share

  119. XUE R, Li X, Deng W, Liang C, et al
    Shared and distinct electroencephalogram microstate abnormalities across schizophrenia, bipolar disorder, and depression.
    Psychol Med. 2024 May 13:1-8. doi: 10.1017/S0033291724001132.
    >> Share

  120. SELTEN JP, Di Forti M, Quattrone D, Jones PB, et al
    The contribution of cannabis use to the increased psychosis risk among minority ethnic groups in Europe.
    Psychol Med. 2024 May 9:1-10. doi: 10.1017/S0033291724001004.
    >> Share

  121. DEMRO C, Lahud E, Burton PC, Purcell JR, et al
    Reward anticipation-related neural activation following cued reinforcement in adults with psychotic psychopathology and biological relatives.
    Psychol Med. 2024;54:1441-1451.
    >> Share

    April 2024
  122. UCOK A, Noyan H, Guloksuz S, Saka MC, et al
    The relationship between childhood trauma, psychotic symptoms, and cognitive schemas in patients with schizophrenia, their siblings, and healthy controls: results from the EU-GEI study.
    Psychol Med. 2024 Apr 12:1-12. doi: 10.1017/S0033291724000540.
    >> Share

  123. MOLINA JL, Joshi YB, Nungaray JA, Sprock J, et al
    Early auditory processing abnormalities alter individual learning trajectories and sensitivity to computerized cognitive training in schizophrenia.
    Psychol Med. 2024 Apr 8:1-8. doi: 10.1017/S0033291724000783.
    >> Share

  124. HJORTHOJ C, Sturup A, Karlsen M, Speyer H, et al
    Use of antipsychotic medication, benzodiazepines, and psychiatric hospitalization in cannabis-related versus cannabis-unrelated schizophrenia - a nationwide, register-based cohort study.
    Psychol Med. 2024 Apr 4:1-10. doi: 10.1017/S0033291724000758.
    >> Share

  125. JORGENSEN KN, Nerland S, Slapo NB, Norbom LB, et al
    Assessing regional intracortical myelination in schizophrenia spectrum and bipolar disorders using the optimized T1w/T2w-ratio.
    Psychol Med. 2024 Apr 2:1-11. doi: 10.1017/S0033291724000503.
    >> Share

  126. HANSEN HG, Gjode ICT, Starzer M, Ranning A, et al
    Clinical illness course and family-related outcomes among parents with a first episode of schizophrenia spectrum disorder: a 20-year follow-up of the OPUS trial.
    Psychol Med. 2024 Apr 2:1-10. doi: 10.1017/S0033291724000680.
    >> Share

  127. WANG J, Luo GY, Tian T, Zhao YQ, et al
    Shared genetic basis and causality between schizophrenia and inflammatory bowel disease: evidence from a comprehensive genetic analysis.
    Psychol Med. 2024 Apr 2:1-11. doi: 10.1017/S0033291724000771.
    >> Share

  128. MARCO-GARCIA S, Ariyo K, Owen GS, David AS, et al
    Decision making capacity for treatment in psychiatric inpatients: a systematic review and meta-analysis.
    Psychol Med. 2024;54:1074-1083.
    >> Share

  129. LAWRENCE JM, Breunig S, Foote IF, Tallis CB, et al
    Genomic SEM applied to explore etiological divergences in bipolar subtypes.
    Psychol Med. 2024;54:1152-1159.
    >> Share

    March 2024
  130. DENG L, Wei W, Qiao C, Yin Y, et al
    Dynamic aberrances of substantia nigra-relevant coactivation patterns in first-episode treatment-naive patients with schizophrenia.
    Psychol Med. 2024 Mar 25:1-11. doi: 10.1017/S0033291724000655.
    >> Share

  131. MELVILLE G, Hoffman M, Pollock A, Kurtz MM, et al
    Do metacognitive therapies for schizophrenia-spectrum disorders work? A meta-analytic investigation.
    Psychol Med. 2024 Mar 21:1-9. doi: 10.1017/S0033291724000564.
    >> Share

  132. CUESTA MJ, Garcia de Jalon E, Sanchez-Torres AM, Gil-Berrozpe GJ, et al
    Additive effects of a family history of schizophrenia spectrum disorders and an environmental risk score for the outcome of patients with non-affective first-episode psychosis.
    Psychol Med. 2024 Mar 20:1-9. doi: 10.1017/S0033291724000576.
    >> Share

  133. LUO C, Pi X, Zhang Q, Hu N, et al
    A subtype of schizophrenia patients with altered methylation level of genes related to immune cell activity.
    Psychol Med. 2024 Mar 20:1-9. doi: 10.1017/S0033291724000667.
    >> Share

  134. FORMICA MJC, Fuller-Tyszkiewicz M, Reininghaus U, Kempton M, et al
    Associations between disturbed sleep and attenuated psychotic experiences in people at clinical high risk for psychosis.
    Psychol Med. 2024 Mar 7:1-10. doi: 10.1017/S0033291724000400.
    >> Share

  135. LIU Y, Ren H, Zhang Y, Deng W, et al
    Temporal changes in brain morphology related to inflammation and schizophrenia: an omnigenic Mendelian randomization study.
    Psychol Med. 2024 Mar 6:1-9. doi: 10.1017/S003329172400014.
    >> Share

  136. BARNES-SCHEUFLER CV, Rosler L, Schaum M, Schiweck C, et al
    External cues improve visual working memory encoding in the presence of salient distractors in schizophrenia.
    Psychol Med. 2024 Mar 4:1-10. doi: 10.1017/S0033291724000059.
    >> Share

  137. ZHANG T, Cui H, Tang X, Xu L, et al
    Models of mild cognitive deficits in risk assessment in early psychosis.
    Psychol Med. 2024 Mar 4:1-12. doi: 10.1017/S0033291724000382.
    >> Share

  138. ROBINSON N, Ploner A, Leone M, Lichtenstein P, et al
    Environmental risk factors for schizophrenia and bipolar disorder from childhood to diagnosis: a Swedish nested case-control study.
    Psychol Med. 2024 Mar 1:1-10. doi: 10.1017/S0033291724000266.
    >> Share

    February 2024
  139. CORSI-ZUELLI F, Quattrone D, Ragazzi TCC, Loureiro CM, et al
    Transdiagnostic dimensions of symptoms and experiences associated with immune proteins in the continuity of psychosis.
    Psychol Med. 2024 Feb 28:1-13. doi: 10.1017/S0033291724000199.
    >> Share

  140. SIMONSEN C, Asbo G, Slade M, Wold KF, et al
    A good life with psychosis: rate of positive outcomes in first-episode psychosis at 10-year follow-up.
    Psychol Med. 2024 Feb 23:1-10. doi: 10.1017/S0033291724000205.
    >> Share

  141. LI X, Vaessen T, Lafit G, van Aubel E, et al
    Higher emotion regulation flexibility predicts more stable negative emotions and faster affective recovery in early psychosis: an experience sampling study.
    Psychol Med. 2024 Feb 12:1-10. doi: 10.1017/S0033291724000151.
    >> Share

  142. STARZER M, Hansen HG, Hjorthoj C, Albert N, et al
    20-year neurocognitive development following a schizophrenia spectrum disorder and associations with symptom severity and functional outcomes.
    Psychol Med. 2024 Feb 12:1-11. doi: 10.1017/S0033291724000096.
    >> Share

  143. GREEN MF, Wynn JK, Eisenberger NI, Horan WP, et al
    Social cognition and social motivation in schizophrenia and bipolar disorder: are impairments linked to the disorder or to being socially isolated?
    Psychol Med. 2024 Feb 5:1-9. doi: 10.1017/S0033291724000102.
    >> Share

  144. TORO VD, Antonucci LA, Quarto T, Passiatore R, et al
    The interaction between early life complications and a polygenic risk score for schizophrenia is associated with brain activity during emotion processing in healthy participants.
    Psychol Med. 2024 Feb 2:1-10. doi: 10.1017/S0033291724000011.
    >> Share

    January 2024
  145. D'ANDREA G, Quattrone D, Malone K, Tripoli G, et al
    Variation of subclinical psychosis across 16 sites in Europe and Brazil: findings from the multi-national EU-GEI study.
    Psychol Med. 2024 Jan 30:1-14. doi: 10.1017/S0033291723003781.
    >> Share

  146. ABPLANALP SJ, Braff DL, Light GA, Joshi YB, et al
    Clarifying directional dependence among measures of early auditory processing and cognition in schizophrenia: leveraging Gaussian graphical models and Bayesian networks.
    Psychol Med. 2024 Jan 30:1-10. doi: 10.1017/S0033291724000023.
    >> Share

  147. KORTE KJ, Jaguga F, Kim HH, Stroud RE, et al
    Psychometric Properties of the Mini International Neuropsychiatric Interview (MINI) Psychosis Module: A Sub-Saharan Africa Cross Country Comparison - CORRIGENDUM.
    Psychol Med. 2024 Jan 10:1. doi: 10.1017/S0033291723003835.
    >> Share

  148. AKCAOGLU Z, Vaessen T, Velthorst E, Lafit G, et al
    The temporal association between social isolation, distress, and psychotic experiences in individuals at clinical high-risk for psychosis.
    Psychol Med. 2024 Jan 5:1-9. doi: 10.1017/S0033291723003598.
    >> Share

  149. BUCHWALD K, Narayanan A, Siegert RJ, Vignes M, et al
    Centrality statistics of symptom networks of schizophrenia: a systematic review.
    Psychol Med. 2024 Jan 4:1-13. doi: 10.1017/S003329172300363.
    >> Share

  150. DENG F, Bueber MA, Cao Y, Tang J, et al
    Assessing social cognition in patients with schizophrenia and healthy controls using the reading the mind in the eyes test (RMET): a systematic review and meta-regression.
    Psychol Med. 2024 Jan 4:1-27. doi: 10.1017/S0033291723003501.
    >> Share

  151. KENDLER KS, Keefe RSE, Ohlsson H, Sundquist J, et al
    Risk for psychiatric and substance use disorders as a function of transitions in Sweden's public educational system: a national study.
    Psychol Med. 2024;54:117-124.
    >> Share

    December 2023
  152. SALAZAR DE PABLO G, Aymerich C, Guinart D, Catalan A, et al
    What is the duration of untreated psychosis worldwide? - A meta-analysis of pooled mean and median time and regional trends and other correlates across 369 studies.
    Psychol Med. 2023 Dec 13:1-11. doi: 10.1017/S0033291723003458.
    >> Share

  153. SAARINEN A, Hietala J, Lyytikainen LP, Hamal Mishra B, et al
    Polygenic risk for schizophrenia predicting social trajectories in a general population sample.
    Psychol Med. 2023 Dec 4:1-9. doi: 10.1017/S003329172300346.
    >> Share

  154. POULOS J, Normand ST, Zelevinsky K, Newcomer JW, et al
    Antipsychotics and the risk of diabetes and death among adults with serious mental illnesses.
    Psychol Med. 2023;53:7677-7684.
    >> Share

    November 2023
  155. COSTAS-CARRERA A, Verdolini N, Garcia-Rizo C, Mezquida G, et al
    Difficulties during delivery, brain ventricle enlargement and cognitive impairment in first episode psychosis.
    Psychol Med. 2023 Nov 28:1-11. doi: 10.1017/S0033291723003185.
    >> Share

  156. WANG B, Otten LJ, Schulze K, Afrah H, et al
    Is auditory processing measured by the N100 an endophenotype for psychosis? A family study and a meta-analysis.
    Psychol Med. 2023 Nov 24:1-14. doi: 10.1017/S0033291723003409.
    >> Share

  157. DI PRINZIO P, Morgan VA
    Early Adversity Scale for Schizophrenia (Short Form) (EAS-Sz (SF)).
    Psychol Med. 2023 Nov 23:1-3. doi: 10.1017/S0033291723003379.
    >> Share

  158. PERALTA D, Janda L, Garcia de Jalon E, Moreno-Izco L, et al
    Long-term diagnostic stability, predictors of diagnostic change, and time until diagnostic change of first-episode psychosis: a 21-year follow-up study.
    Psychol Med. 2023 Nov 21:1-10. doi: 10.1017/S0033291723003173.
    >> Share

  159. MARTIN MC
    Correspondence to Freeman et al. (2023)'s virtual reality (VR) therapy for patients with psychosis: satisfaction and side effects.
    Psychol Med. 2023 Nov 6:1-2. doi: 10.1017/S0033291723003100.
    >> Share

  160. LIVINGSTON NR, Fusar-Poli P, Modinos G
    Letter to the Editor on 'Baseline benzodiazepine exposure is associated with greater risk of transition in clinical high-risk for psychosis (CHR-P): a meta-analysis'.
    Psychol Med. 2023 Nov 3:1-2. doi: 10.1017/S0033291723003203.
    >> Share

  161. TROTTA G, Rodriguez V, Quattrone D, Spinazzola E, et al
    Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case-control study.
    Psychol Med. 2023;53:7375-7384.
    >> Share

  162. JAYASINGHE A, Wrobel A, Filia K, Byrne LK, et al
    Distress, burden, and wellbeing in siblings of people with mental illness: a mixed studies systematic review and meta-analysis.
    Psychol Med. 2023;53:6945-6964.
    >> Share

    October 2023
  163. VARESE F, Sellwood W, Pulford D, Awenat Y, et al
    Trauma-focused therapy in early psychosis: results of a feasibility randomized controlled trial of EMDR for psychosis (EMDRp) in early intervention settings.
    Psychol Med. 2023 Oct 26:1-12. doi: 10.1017/S0033291723002532.
    >> Share

  164. KAPLER S, Adery L, Hoftman GD, Amir CM, et al
    Assessing evidence supporting cannabis harm reduction practices for adolescents at clinical high-risk for psychosis: a review and clinical implementation tool.
    Psychol Med. 2023 Oct 26:1-11. doi: 10.1017/S0033291723002994.
    >> Share

  165. PETKARI E, Nikolaou E, Oberleiter S, Priebe S, et al
    Which psychological interventions improve quality of life in patients with schizophrenia-spectrum disorders? A meta-analysis of randomized controlled trials.
    Psychol Med. 2023 Oct 20:1-24. doi: 10.1017/S0033291723003070.
    >> Share

  166. DAVIES C, Bossong MG, Martins D, Wilson R, et al
    Increased hippocampal blood flow in people at clinical high risk for psychosis and effects of cannabidiol.
    Psychol Med. 2023 Oct 17:1-11. doi: 10.1017/S0033291723002775.
    >> Share

  167. MULLIGAN LD, Varese F, Harris K, Haddock G, et al
    Alcohol use and suicide-related outcomes in people with a diagnosis of schizophrenia: a comprehensive systematic review and meta-analysis.
    Psychol Med. 2023 Oct 11:1-12. doi: 10.1017/S0033291723002738.
    >> Share

  168. VENTURA J, Subotnik KL, Han S, Hellemann GS, et al
    The relationship between sex and functional outcome in first-episode schizophrenia: the role of premorbid adjustment and insight.
    Psychol Med. 2023;53:6878-6887.
    >> Share

  169. CAMPBELL-SILLS L, Papini S, Norman SB, Choi KW, et al
    Associations of polygenic risk scores with posttraumatic stress symptom trajectories following combat deployment.
    Psychol Med. 2023;53:6733-6742.
    >> Share

  170. HAN S, Xue K, Chen Y, Xu Y, et al
    Identification of shared and distinct patterns of brain network abnormality across mental disorders through individualized structural covariance network analysis.
    Psychol Med. 2023;53:6780-6791.
    >> Share

    September 2023
  171. YAU KC, Revill G, Blackman G, Shaikh M, et al
    Pediatric traumatic brain injury as a risk factor for psychosis and psychotic symptoms: a systematic review and meta-analysis.
    Psychol Med. 2023 Sep 29:1-9. doi: 10.1017/S0033291723002878.
    >> Share

  172. HOTTE-MEUNIER A, Penney D, Mendelson D, Thibaudeau E, et al
    Effects of metacognitive training (MCT) on social cognition for schizophrenia spectrum and related psychotic disorders: a systematic review and meta-analysis.
    Psychol Med. 2023 Sep 29:1-7. doi: 10.1017/S0033291723002611.
    >> Share

  173. GOH KK, Kanahara N, Chiu YH, Lu ML, et al
    The impact of childhood trauma exposure on social functioning in schizophrenia: the moderated mediation role of oxytocin and oxytocin receptor gene polymorphisms.
    Psychol Med. 2023 Sep 18:1-13. doi: 10.1017/S003329172300274.
    >> Share

  174. BIAGGI A, Hazelgrove K, Waites F, Bind RH, et al
    Mother-infant interaction and infant development in women at risk of postpartum psychosis with and without a postpartum relapse.
    Psychol Med. 2023 Sep 14:1-12. doi: 10.1017/S0033291723002568.
    >> Share

  175. DONALDSON KR, Jonas K, Foti D, Larsen EM, et al
    Mismatch negativity and clinical trajectories in psychotic disorders: Five-year stability and predictive utility.
    Psychol Med. 2023;53:5818-5828.
    >> Share

  176. HAVERS L, von Stumm S, Cardno AG, Freeman D, et al
    Psychotic experiences and negative symptoms from adolescence to emerging adulthood: developmental trajectories and associations with polygenic scores and childhood characteristics.
    Psychol Med. 2023;53:5685-5697.
    >> Share

    July 2023
  177. SEGURA AG, Mezquida G, Martinez-Pinteno A, Gasso P, et al
    Link between cognitive polygenic risk scores and clinical progression after a first-psychotic episode.
    Psychol Med. 2023;53:4634-4647.
    >> Share

  178. MA R, Romano E, Ashworth M, Yadegarfar ME, et al
    Multimorbidity clusters among people with serious mental illness: a representative primary and secondary data linkage cohort study.
    Psychol Med. 2023;53:4333-4344.
    >> Share

  179. SHUNKAI L, Chen P, Zhong S, Chen G, et al
    Alterations of insular dynamic functional connectivity and psychological characteristics in unmedicated bipolar depression patients with a recent suicide attempt.
    Psychol Med. 2023;53:3837-3848.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016